SynthesisCardiovascular diabetology2022

Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis.

Arnaud D Kaze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.